Cited by 45Cholesterol and Lipid MetabolismLipid metabolism and disordersLipoproteins and Cardiovascular Health

Role of the Liver in the Degradation of Lipoproteins

Cooper, Allen D.·1985·Gastroenterology

Integrity signals

Registry

Crossref · 10.1016/s0016-5085(85)80155-4

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased circulating chylomicron-remnant particles are preferentially taken up by the liver by a receptor-mediated process, resulting in nonalcoholic fatty liver disease and hepatic insulin resistance.

    “Increased concentrations of circulating chylomicron-remnant particles are then preferentially taken up by the liver by means of a receptor-mediated process,18–22 resulting in non-alcoholic fatty liver disease and hepatic insulin resistance.”

Cites

Flagged first, then by citations

1 of the 108 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Cooper, A. D.
Affiliations
Stanford Medicine (US)
Corresponding author
Cooper, Allen D.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
1985-01
Volume
88
Issue
1
Pages
192-205
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2094411827
Cited by
45
References
108
Citations by year
2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 2 · 2014: 1
FWCI
1.47
Type
journal article
Language
en
Open access
closed
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01am018774-11)
  • National Heart, Lung, and Blood Institute (HL-05360)
Topics
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
liver, lipoprotein degradation, lipoprotein metabolism, lipid homeostasis, chylomicrons, VLDL, low-density lipoprotein, high-density lipoprotein, triglycerides, atherosclerosis, gallstones
MeSH terms
Animals, Apoproteins, Carrier Proteins, Cell Membrane, Cholesterol, Chylomicrons, Dogs, Humans, Phosphatidylcholine-Sterol O-Acyltransferase, Lipoproteins, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Liver, Liver Diseases, Protein Binding, Rabbits, Receptors, Cell Surface, Receptors, LDL, RNA-Binding Proteins, Receptors, Lipoprotein, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review